DC Devices Lands $34,000,000 Series D Financing Round

  • Feed Type
  • Date
  • Company Name
    DC Devices
  • Mailing Address
    1 Highwood Drive Tewksbury, MA 01876 USA
  • Company Description
    DC Devices is developing the first trans-catheter device for diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). The company’s proprietary and innovative IASD (Inter-Atrial Shunt Device) system is minimally invasive and is designed to relieve increased left atrial pressure (LAp), the main cause of DHF/HFpEF symptoms.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series D
  • Proceeds Purposes
    Funds will be used to complete clinical evaluation of the world’s first transcatheter device for the treatment of diastolic heart failure (DHF), a $5 billion global market opportunity.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy